Microdose GLP-1 therapy uses lower doses of compounded semaglutide or tirzepatide to provide a gentler metabolic effect. It is designed for individuals who want steady, gradual support with fewer or milder side effects compared to standard-dose protocols. It is particularly well-suited for first-time users, individuals sensitive to GLP-1 medications, or those seeking a more gradual metabolic ramp-up.
⚠ Compounded microdose medications offered through Lttl are not FDA-approved. Prescription required following provider evaluation.
Comments
0 comments
Please sign in to leave a comment.